Astringent Powder, For Solution
NDC Package 63561-0178-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Astringent (calcium acetate monohydrate and aluminum sulfate tetradecahydrate) powders is dissolve 1 to 3 packets in a pint (16 oz) of cool or warm waterstir until fully dissolved; do not strain or filter. This formulation utilizes a powder, for solution delivery system. Marketed by Granulation Technology, Inc., this product is identified by NDC 63561-0178 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
63561-0178-2
Package Description
12 PACKET in 1 CARTON / 2299 mg in 1 PACKET (63561-0178-1)
Product Code
63561-0178
11-Digit Billing Format
63561017802
RxNorm Crosswalk
  • RxCUI: 1250234 - aluminum sulfate 1347 MG / calcium acetate 952 MG in 160 ML Topical Solution
  • RxCUI: 1250234 - aluminum sulfate 8.42 MG/ML / calcium acetate 5.95 MG/ML Topical Solution
  • RxCUI: 1250234 - (3 Packets (aluminum sulfate 1347 MG Powder / calcium acetate 952 MG Powder)) per 16 OZ Topical Solution
  • RxCUI: 1250234 - aluminum sulfate 1347 MG / calcium acetate 952 MG per 160 ML Topical Solution

Clinical Specifications

Proprietary Name
Astringent
Non-Proprietary Name
Calcium Acetate Monohydrate And Aluminum Sulfate Tetradecahydrate
Substance Name
Aluminum Sulfate Tetradecahydrate; Calcium Acetate Monohydrate
Dosage Form
Powder, For Solution - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Dissolve 1 to 3 packets in a pint (16 oz) of cool or warm waterstir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use.For use as a soak:soak affected area for 15 to 30 minutes as needed, or as directed by a doctorrepeat 3 times a day or as directed by a doctordiscard solution after each useFor use as a compress or wet dressing:soak a clean, soft cloth in the solutionapply cloth loosely to affected area for 15 to 30 minutesrepeat as needed or as directed by a doctordiscard solution after each use

Regulatory & Marketing

Labeler Name
Granulation Technology, Inc.
Product Type
Human Otc Drug
FDA Application #
part347
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-12-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63561-0178-2 identifies a specific commercial package of 12 packet in 1 carton / 2299 mg in 1 packet (63561-0178-1) of Astringent, a human over the counter drug labeled by Granulation Technology, Inc.. This powder, for solution is formulated for topical use and contains aluminum sulfate tetradecahydrate; calcium acetate monohydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Granulation Technology, Inc. on June 12, 2025. The current certification is valid through December 31, 2026.

How is this Granulation Technology, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63561017802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
63561-0178-2
11-Digit CMS (5-4-2)
63561-0178-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.